These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3713515)

  • 1. Short-term effects of fluoride and strontium on bone formation and resorption in the mouse.
    Marie PJ; Hott M
    Metabolism; 1986 Jun; 35(6):547-51. PubMed ID: 3713515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of low doses of stable strontium on bone metabolism in rats.
    Marie PJ; Garba MT; Hott M; Miravet L
    Miner Electrolyte Metab; 1985; 11(1):5-13. PubMed ID: 3974537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strontium increases vertebral bone volume in rats at a low dose that does not induce detectable mineralization defect.
    Grynpas MD; Hamilton E; Cheung R; Tsouderos Y; Deloffre P; Hott M; Marie PJ
    Bone; 1996 Mar; 18(3):253-9. PubMed ID: 8703581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of bone matrix apposition by (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (AHPrBP) in the mouse.
    Marie PJ; Hott M; Garba MT
    Bone; 1985; 6(3):193-200. PubMed ID: 4027097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasting effects of 1,25-dihydroxyvitamin D3 on bone matrix and mineral appositional rates in the mouse.
    Marie PJ; Hott M; Garba MT
    Metabolism; 1985 Aug; 34(8):777-83. PubMed ID: 3839559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of short-term fluoride ingestion on bone formation and resorption in the rat femur.
    Ream LJ
    Cell Tissue Res; 1981; 221(2):421-30. PubMed ID: 7307063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by aminohydroxypropylidene bisphosphonate (AHPrBP) of 1,25(OH)2 vitamin D3-induced stimulated bone turnover in the mouse.
    Marie PJ; Hott M; Garba MT
    Calcif Tissue Int; 1985 May; 37(3):268-75. PubMed ID: 3926276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of magnesium supplementation on bone turnover in the normal young mouse.
    Marie PJ; Travers R; Delvin EE
    Calcif Tissue Int; 1983 Sep; 35(6):755-61. PubMed ID: 6652550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of calcitonin on the magnesium-induced bone resorption in the mouse.
    Marie PJ; Hott M
    Magnesium; 1987; 6(2):100-8. PubMed ID: 3573817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quantitative histologic study of the effects of fluoride on resorption and formation in animal and human bone.
    Epker BN
    Clin Orthop Relat Res; 1966; 49():77-87. PubMed ID: 5962625
    [No Abstract]   [Full Text] [Related]  

  • 11. Strontium ranelate: a novel mode of action optimizing bone formation and resorption.
    Marie PJ
    Osteoporos Int; 2005 Jan; 16 Suppl 1():S7-10. PubMed ID: 15578159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment with strontium ranelate increases vertebral bone mass without deleterious effect in mice.
    Delannoy P; Bazot D; Marie PJ
    Metabolism; 2002 Jul; 51(7):906-11. PubMed ID: 12077740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation.
    Marie PJ
    Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S11-5. PubMed ID: 16735840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
    Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
    Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of fluoride on bone and implant histomorphometry in growing rats.
    Turner RT; Francis R; Brown D; Garand J; Hannon KS; Bell NH
    J Bone Miner Res; 1989 Aug; 4(4):477-84. PubMed ID: 2816497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoride and strontium accumulation in bone does not correlate with osteoid tissue in dialysis patients.
    Cohen-Solal ME; Augry F; Mauras Y; Morieux C; Allain P; de Vernejoul MC
    Nephrol Dial Transplant; 2002 Mar; 17(3):449-54. PubMed ID: 11865091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of fluoride and strontium application on dentin: in vivo and in vitro studies.
    Gedalia I; Brayer L; Kalter N; Richter M; Stabholz A
    J Periodontol; 1978 May; 49(5):269-72. PubMed ID: 277678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture.
    Van Beek E; Van der Wee-Pals L; van de Ruit M; Nijweide P; Papapoulos S; Löwik C
    J Bone Miner Res; 1993 Feb; 8(2):191-8. PubMed ID: 8442437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strontium substitution in apatitic CaP cements effectively attenuates osteoclastic resorption but does not inhibit osteoclastogenesis.
    Schumacher M; Wagner AS; Kokesch-Himmelreich J; Bernhardt A; Rohnke M; Wenisch S; Gelinsky M
    Acta Biomater; 2016 Jun; 37():184-94. PubMed ID: 27084107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoride effects on bone formation and mineralization are influenced by genetics.
    Mousny M; Omelon S; Wise L; Everett ET; Dumitriu M; Holmyard DP; Banse X; Devogelaer JP; Grynpas MD
    Bone; 2008 Dec; 43(6):1067-74. PubMed ID: 18755305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.